ABSTRACT
Although Enzyme Linked Immuno Sorbent Assay (ELISA) technology is approaching it's 45th year of existence since first described in 1971, it is still the main diagnostic tool in clinical research and routine diagnostics. However, despite its broad usage it suffers from some drawbacks, limiting its use especially in more advanced assay formats like multiplexing platforms, point of care devices or protein arrays. Those limitations result from the need for an enzyme label, a soluble enzyme substrate, washing steps (multiplexing, point care, arrays) and in some cases also insufficient sensitivity, because the majority of circulating proteins and thus potential biomarkers may be found in lower sub-picomolar concentrations. We hereby present a new assay platform based on metal enhanced fluorescence (MEF), that remedies these problems since it eliminates the need for washing steps, for using enzyme labels and allows detection of analytes down to sub-picomolar concentrations. In addition this technology is fully compatible to standard fluorescence reader equipment as it is found in many laboratories nowadays. Since our present work is focused on single biomarker evaluation, we chose a 96 well plate format for convenience, but any other formate like antibody arrays, strip-like point of care devices etc. is feasible too.
Subject(s)
Metals/chemistry , Point-of-Care Systems , Fluoroimmunoassay/instrumentation , Fluoroimmunoassay/methods , HumansABSTRACT
A highly sensitive method for measuring the activity of the enzyme diamine oxidase (DAO) independent of the type of substrate is described. The principle of the assay is to determine the amount hydrogen peroxide generated as a reaction product during oxidation of diamines by DAO. PSatto, a highly sensitive luminescence reagent, was used to generate a signal depending on the hydrogen peroxide concentration based on the action of horseradish peroxidase. DAO is specifically captured from a sample by an antibody immobilized to microwell plates, and the substrate is added to the bound enzyme. Various diamines were used as substrates; the peroxide produced is directly proportional to the amount of DAO bound to the specific antibodies. With this very sensitive method, it is possible to detect pmol amounts of generated hydrogen peroxide in plasma matrix corresponding to the biological activity of DAO.
Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Indicators and Reagents/chemistry , Luminescence , Amine Oxidase (Copper-Containing)/blood , Animals , Diamines/chemistry , Diamines/metabolism , Humans , Hydrogen Peroxide/metabolism , Indicators and Reagents/metabolism , Kidney/enzymology , Kinetics , Luminescent Measurements/methods , Models, Chemical , Molecular Structure , Oxidation-Reduction , Putrescine/metabolism , Reproducibility of Results , SwineABSTRACT
Proatrial natriuretic peptides are proposed to be sensitive and specific markers for various stages of heart deficiency. Here we present a rapid and specific sandwich immunoassay for the measurement of proANP 1-98 in biological fluids like plasma, serum urine. No sample preparation prior to the assay is necessary. Polyclonal antibodies specific for distinct epitopes of proANP 1-98, predicted to be highly immunogenic, were raised in sheep and purified by immunoaffinity chromatography prior to use in the assay. Antigen binding sites of the antibodies were determined by epitope mapping with a set of peptide fragments. The capture antibody, specific for proANP 16-23, is coated directly onto microtiter plates. Recombinant proANP 1-98 is used as a standard. The biotinylated detection antibody, specific for proANP 80-88, is incubated simultaneously with 20microl of sample for 150 min. Signal is generated with a streptavidin-HRPO-conjugate and TMB as substrate. The detection limit of the assay is 50 pmol/l; intraassay CVs are below 5%, interassay CVs are lower than 10%. Dilution curves show good linearity, recovery of synthetic peptide ranged between 85% and 91%. Reference values from healthy volunteers range from 0 to 2000 pmol/l in human plasma. We conclude this assay is a easy to handle, quick and reliable method for routine measurement of proANP 1-98 and the presented manuscript describes the procedure and performance of this ELISA in detail.
Subject(s)
Atrial Natriuretic Factor/analysis , Enzyme-Linked Immunosorbent Assay/methods , Protein Precursors/analysis , Ventricular Dysfunction, Left/metabolism , Animals , Atrial Natriuretic Factor/blood , Atrial Natriuretic Factor/standards , Enzyme-Linked Immunosorbent Assay/standards , Fluorescent Antibody Technique, Indirect/methods , Fluorescent Antibody Technique, Indirect/standards , Humans , Peptide Fragments , Protein Precursors/blood , Protein Precursors/standards , SheepABSTRACT
Several peptides derived from the N-terminal sequence of pro-atrial natriuretic peptide (proANP) have been tested successfully as markers of heart disease. We have developed specific and sensitive competitive enzyme immunoassays for fragments [1-30] and [31-67] of proANP. Antisera were raised in sheep against synthetic peptides predicted to be highly immunogenic. Binding specificity was determined by epitope mapping. Microtiter plates were coated with antibody specific for the Fc region of sheep IgG to capture the affinity-purified specific anti-proANP antibodies in an oriented and reproducible form. Synthetic proANP calibrators or diluted samples were incubated simultaneously with biotinylated peptide and binding was quantitated using streptavidin-peroxidase and TMB. Immunoreactive proANP could be measured in diluted plasma, serum and urine. The detection limits of the proANP[1-30] and proANP[31-67] assays were 2.5 and 10 pmol/l respectively. The linearity of samples diluted beyond the recommended assay conditions was good. Recoveries of added standard peptides ranged from 102 to 112%. Circulating concentrations of immunoreactive proANP in 115 healthy subjects ranged from 0.11 to 0.47 nmol/l proANP[1-30] and 0.18 to 0.79 nmol/l proANP[31-67]. In patients with cardiac disease, proANP levels were increased significantly. The reference interval of proANP[31-67] in urine was 0.09 to 1.7 nmol/l, several-fold higher than proANP[1-30] (Subject(s)
Atrial Natriuretic Factor/chemistry
, Epitopes/chemistry
, Immunoenzyme Techniques/methods
, Protein Precursors/chemistry
, Animals
, Atrial Natriuretic Factor/blood
, Atrial Natriuretic Factor/urine
, Enzyme Stability
, Enzyme-Linked Immunosorbent Assay/methods
, Epitope Mapping
, Heart Diseases/blood
, Heart Diseases/urine
, Humans
, Protein Precursors/blood
, Protein Precursors/urine
, Sheep
, Time Factors
ABSTRACT
OBJECT: Whereas the removal of subarachnoid blood is possible during early-stage aneurysm surgery, this cannot be achieved in aneurysms treated by endovascular means. The levels of potential spasmogens in the cerebrospinal fluid (CSF) in patients receiving endovascular treatment might therefore be higher, with the potential for more severe post-subarachnoid hemorrhage (SAH) vasospasm. METHODS: Serum and CSF concentrations of big endothelin (ET)-1 were serially measured in patients with SAH receiving one of the following treatments: 1) early (within 72 hours of SAH) aneurysm surgical treatment (15 patients), 2) early endovascular treatment (17 patients), or 3) no intervention in the acute phase (12 patients). In patients suffering delayed infarctions higher levels of big ET-1 CSF were demonstrated than in those without infarctions (p = 0.01). In patients in whom surgery was performed in the acute phase lower big ET-1 CSF concentrations were demonstrated than in those who received embolization treatment or no treatment (p = 0.02). Subgroup analysis demonstrated that in patients receiving early endovascular treatment, higher big ET-1 CSF concentrations were revealed than in those undergoing early aneurysm surgery; this was true for patients with (microsurgerytreated, 1.84 +/- 0.83 pg/ml; and embolization-treated 2.19 +/- 0.54 pg/ml) and without (microsurgery-treated 1.76 +/- 0.61 pg/ml; and embolization-treated 2.01 +/- 0.48 pg/ml) delayed infarctions. CONCLUSIONS: Among patients with SAH who received treatment during the acute phase, those undergoing early aneurysm surgery were shown to have lower big ET-1 CSF levels than those receiving embolization and no treatment (that is, the nonsurgical treatment groups). The clinical significance of this finding remains to be established in future clinical trials, because in the present study the trend toward lower levels of big ET-1 CSF in the microsurgically treated group was not paralleled by a lower delayed stroke rate or an improvement in neurological outcome.
Subject(s)
Aneurysm, Ruptured/blood , Aneurysm, Ruptured/surgery , Endothelin-1/blood , Endothelin-1/cerebrospinal fluid , Intracranial Aneurysm/blood , Intracranial Aneurysm/cerebrospinal fluid , Adult , Aged , Aged, 80 and over , Aneurysm, Ruptured/cerebrospinal fluid , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Intracranial Aneurysm/surgery , Male , Middle Aged , Time FactorsABSTRACT
Urodilatin (95-126) (URO) appears to play a major physiologic role in fluid homeostasis and produces major changes when administered intravenously. Here we describe a monospecific, high-affinity antiserum against URO with no cross-reactivity (<0.01%) against the structural highly homologous atrial natriuretic peptide 99-126 (ANP-99-126), ANP analogs, and related peptides such as brain natriuretic peptide. A competitive RIA was developed, based on this antiserum. Urine samples with or without ethanol extraction and plasma samples without pretreatment were analyzed by the RIA, which had a detection limit of 10.5 ng/L, a linear measuring range between 10.5 and 1000 ng/L, and recoveries of 93-102% in urine and 90-104% in plasma. The intraassay CVs were 8.2% and 8.1% for urine samples with 269 and 669 ng/L URO; the interassay CV was 9.7% at 839 ng/L. Using this assay, we present URO data for urine from healthy volunteers receiving low and routine sodium diets and from clinical urine specimens; we also present pharmacokinetic data for URO in plasma from patients suffering from bronchial asthma and treated by URO infusion.
Subject(s)
Atrial Natriuretic Factor/analysis , Bronchodilator Agents/analysis , Diuretics/analysis , Immune Sera , Peptide Fragments/analysis , Animals , Antibody Specificity , Asthma/drug therapy , Asthma/metabolism , Atrial Natriuretic Factor/blood , Atrial Natriuretic Factor/immunology , Atrial Natriuretic Factor/urine , Bronchodilator Agents/blood , Bronchodilator Agents/immunology , Bronchodilator Agents/urine , Cardiac Catheterization , Diuretics/blood , Diuretics/immunology , Diuretics/urine , Infusions, Intravenous , Male , Peptide Fragments/blood , Peptide Fragments/immunology , Peptide Fragments/urine , Rabbits , Radioimmunoassay , Sheep , Sodium, Dietary/administration & dosageABSTRACT
High endothelin (ET) concentrations were recently detected in human bile after orthotopic liver transplantation (OLT). In the present study we compared biliary ET/big-ET levels measured by radioimmunoassay (RIA) in liver graft recipients (n = 37) with levels measured in non-transplant patients during cholecystectomy (n = 38) to clarify the influence of transplantation on the levels of biliary ET peptides. HPLC elution profiles of biliary ET were analyzed for characterization of ET peptide composition and validation of RIA analysis in bile extracts. Mean ET/big-ET levels in the common bile duct after OLT were significantly elevated (ET, 20.9 +/- 15; big-ET, 39.2 +/- 19 fmol/ml) compared to levels in non-transplant patients (ET, 5.7 +/- 4.9; big-ET, 12 +/- 8 fmol/ml). Highest ET/big-ET levels were measured in the gall bladder during cholecystectomy (ET, 61.7 +/- 41; big-ET, 75 +/- 28 fmol/ml). ET and big-ET levels were correlated by linear regression. HPLC analysis reveals the presence of high levels of ET/big-ET in human bile. Biliary ET mostly represents ET-1. High biliary ET levels after OLT appear to be derived from active endothelial secretion and probably reflect hepatic endothelial stress after preservation/ reperfusion. High biliary ET levels could be involved in the mediation of functional cholestatic syndromes after OLT.
Subject(s)
Bile/chemistry , Cholecystectomy , Endothelins/analysis , Liver Transplantation , Adult , Aged , Chromatography, High Pressure Liquid , Endothelins/immunology , Female , Humans , Male , Middle AgedABSTRACT
Two alpha-human atrial natriuretic peptide (alpha-hANP) based affinity chromatography columns were produced by covalently immobilizing the C- and N-terminal epitopes of alpha-hANP. The stationary phase was made from a controlled-pore-glass bead solid support, which was silanized and treated with sulphosuccinimidyl 4-(maleimidomethyl)cyclohexyl carboxylate before the individual fragments were immobilized by substitution at their thiol groups. These columns were used to isolate alpha-hANP-specific antibodies from a goat anti-alpha-hANP serum, which were then further sorted according to their epitope specifity. These C- and N-terminal epitope-specific antibodies were in turn used as components in the construction of an alpha-hANP biosensor based on an enzyme-linked immunosorbent assay (ELISA) sandwich principle. Initial in vitro testing of the sensor using a physiological alpha-hANP solution showed a reproducible response to the peptide. There is to date no other equally fast, sensitive and precise method available to detect this peptide. This alpha-hANP sensor may prove to be an invaluable aid in human medicine as a monitor of patient status during transplant surgery, for example, an area inaccessible to radioimmunoassay and normal ELISA techniques.
Subject(s)
Antibodies/isolation & purification , Atrial Natriuretic Factor , Biosensing Techniques , Chromatography, Affinity/instrumentation , Epitopes/isolation & purification , Peptide Fragments , Amino Acid Sequence , Enzyme-Linked Immunosorbent Assay , Humans , Molecular Sequence DataABSTRACT
Two polyclonal antisera from goat and mouse and two monoclonal antibodies against human parathyroid hormone (1-34) were characterised by epitope mapping. Hexapeptides were synthesized on polystyrene pins, the sequences of which overlapped and represented the entire sequence of hPTH(1-34). Binding of antibodies to these hexapeptides was determined and antigenic determinants thus characterized. At least one predominant binding sequence was detected in the region of hPTH(7-14).
Subject(s)
Parathyroid Hormone/immunology , Peptide Fragments/immunology , Amino Acid Sequence , Antibodies , Antibodies, Monoclonal , Epitopes/chemistry , Humans , Immunochemistry , Models, Molecular , Molecular Sequence Data , Parathyroid Hormone/chemistry , Peptide Fragments/chemistry , Peptide Mapping , Protein Conformation , TeriparatideABSTRACT
Endothelin, a potent endogenous vaso-constrictor, is derived from its biosynthetic precursor by proteolytic degradation. The last step cleaves big-endothelin(1-38) to endothelin(1-21) and a C-terminal fragment. We have developed a radioimmunoassay for this peptide, based on an antiserum recognizing the C-terminal sequence big-endothelin(22-38) and cross-reacting with intact big-endothelin. To test for the presence of immunoreactive big-endothelin(22-38) in plasma, samples were extracted by passage through C18 silica cartridges, and desorption with methanol/water volume fraction 0.8. The yields of this purification and concentration procedure were about 70%. In 15 healthy persons we found concentrations of 1-11 pmol/l, which is about 10-fold higher than the reference levels reported for endothelin(1-21) or big-endothelin(1-38). Thus, endothelin-derived peptides containing the big-endothelin(22-38) sequence, but different from intact big-endothelin, do circulate in human blood. If a sufficiently tight correlation to levels of circulating endothelin(2-21) can be proven, this would facilitate studies on the physiological role of endogenous endothelin.
Subject(s)
Endothelins/blood , Protein Precursors/blood , Endothelin-1 , Endothelins/chemistry , Endothelins/isolation & purification , Humans , Peptide Fragments/isolation & purification , Radioimmunoassay/methods , Reference ValuesABSTRACT
alpha-Human atrial natriuretic peptide (alpha-hANP) was covalently coupled via single attachment onto two different insoluble matrices. Controlled-pore glass-alpha-hANP matrices were well suited for the purification of monospecific antibodies, whereas Enzacryl AA-alpha-hANP did not withstand the inevitable chemical and physical stresses during affinity purification.
Subject(s)
Atrial Natriuretic Factor/isolation & purification , Animals , Antibodies/isolation & purification , Antibody Specificity , Atrial Natriuretic Factor/immunology , Chromatography, Affinity , Goats/immunology , Humans , RadioimmunoassayABSTRACT
Employing HPLC coupled with RIA, it was shown that alpha-human atrial natriuretic peptide is excreted in urine. Freshly collected urine had to be acidified to obtain reproducible results. When prepurified urine was subjected to HPLC (ion exchange and reversed phase) the subsequent quantification of alpha-hANP immunoreactive material in the eluate showed 10- to 30-fold greater amounts of alpha-hANP after treatment with HPLC; substances with the same elution parameters as synthetic alpha-hANP were detected, but they gave no response in the RIA.
Subject(s)
Atrial Natriuretic Factor/urine , Atrial Natriuretic Factor/metabolism , Chromatography, High Pressure Liquid , Chromatography, Ion Exchange , Humans , RadioimmunoassayABSTRACT
Plasma membranes were isolated and separated from thylakoid membranes by discontinuous sucrose density gradient centrifugation of crude membranes prepared by French pressure cell extrusion of lysozyme-treated Anacystis nidulans. Two distinct populations of chlorophyll-free plasma membrane vesicles were obtained exhibiting buoyant densities of 1.087 and 1.100 g/cm3 as opposed to a uniform density of 1.192 g/cm3 for thylakoid membranes. Plasma and thylakoid membranes were characteristically different also with respect to fatty acid and protein composition, cytochrome oxidase activity, and pigment content as analyzed by spectrophotometry, spectrofluorimetry, and high performance liquid chromatography. Apart from carotenoids, chlorophyll a was the only major photosynthetic pigment detected in thylakoid membranes while plasma membranes contained virtually no chlorophyll a but (besides large amounts of carotenoids) protochlorophyllide a and chlorophyllide a as revealed by solvent partition (between n-hexane and acetone or methanol), room and low temperature fluorescence emission and excitation spectra, and analytical separation and identification by high performance liquid chromatography and comparison with authentic standards. The protochlorophyllide in the plasma membrane could be transformed into chlorophyllide in the dark in vitro by incubating the membrane preparation with NADPH; NADP+ effected the reverse transition.
Subject(s)
Chlorophyll/analogs & derivatives , Chlorophyllides/analysis , Cyanobacteria/metabolism , Cell Membrane/metabolism , Chlorophyll/biosynthesis , Chromatography, High Pressure Liquid , Fatty Acids/analysis , Spectrometry, Fluorescence , Spectrum AnalysisABSTRACT
A light plasma membrane fraction corresponding to a buoyant density of 1.087 +/- 0.005 g/cm3 and devoid of chlorophyll was prepared and purified from Anacystis nidulans according to a recently published procedure (G.A.Peschek, V.Molitor, M.Trnka, M. Wastyn and W. Erber (1988) Methods Enzymol. 167, 437-449). Besides major amounts of carotenoids the plasma membranes contained a small but significant pool of chlorophyllide a and protochlorophyllide a as verified by room temperature and 77K spectrofluorimetry and analytical separation and identification by high performance liquid chromatography using authentic standards. Incubation of the plasma membranes in strict darkness in the presence of NADPH was accompanied by the gradual and stoichiometric replacement of protochlorophyllide by chlorophyllide, NADP+ effecting the reverse transition. The reaction was completely insensitive to illumination (5-20 w/m2 tungsten light) but abolished after heating of the membranes (90 degrees C, 5 min) or in the presence of 10 mM EGTA, and was specifically stimulated by calcium ions. Our results indicate the occurrence of light-independent NADPH:protochlorophyllide oxidoreductase activity in the plasma membrane of Anacystis nidulans.
Subject(s)
Cyanobacteria/enzymology , Light , Oxidoreductases Acting on CH-CH Group Donors , Oxidoreductases/metabolism , Cell Membrane/enzymology , Cell Membrane/metabolism , Cell Membrane/physiology , Chlorophyll/biosynthesis , Chlorophyll/metabolism , Chromatography, High Pressure Liquid , Cyanobacteria/metabolism , Cyanobacteria/physiology , Light-Harvesting Protein Complexes , Photosynthetic Reaction Center Complex Proteins , Plant Proteins/biosynthesis , Plant Proteins/metabolism , Spectrometry, FluorescenceABSTRACT
Plasma and thylakoid membranes were isolated and purified from the cyanobacterium Anacystis nidulans. Spectrophotometric examination of acetone extracts gave major absorption bands resulting from carotenoids and chlorophyll a in plasma and thylakoid membranes, respectively. Only a very small absorption peak at 663 nm was detected in acetone extracts of plasma membranes which, in contrast to the corresponding peak from thylakoid membranes, could not be extracted into n-hexane; methanol, on the other hand, was effective with both plasma and thylakoid membranes. Aqueous membrane suspensions excited at 435 nm gave strong fluorescence emission at 662 nm for plasma membranes, but only a very small one for thylakoid membranes which had been adjusted to equal absorbance at 678 nm. Excitation spectra of the 668 nm fluorescence emission peak in acetone extracts of plasma and thylakoid membranes were strikingly different from each other. Finally, high performance liquid chromatography afforded clear-cut preparative separation of the two "chlorophyll-like" pigments in plasma and thylakoid membranes, respectively, and identification by comparison with retention characteristics known from the literature, together with a pure chlorophyll a standard. Our results indicate that the highly fluorescent and polar "chlorophyll-like" pigment in plasma membranes of Anacystis is a chlorophyll precursor, viz. chlorophyllide a.